HIGHLIGHTS
SUMMARY
This program will use implementation research methodology to understand the impact of determinants and specific strategies on blinatumomab adoption and iteratively integrate knowledge to refine the program and create a resource-informed, reproducible, scalable, and adaptable model, the "Implementation Roadmap for Translation of Novel Therapies," hereafter referred to as the Implementation Roadmap. As the first step in this program, a diverse group of collaborators was assembled to develop a comprehensive understanding of multilevel barriers and facilitators impacting blinatumomab implementation in LMICs. A quantitative implementation strategy feedback survey 12 months after training. This information will . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.